Latest news
JAZZ Q2 Earnings Miss, Sales Beat, Stock Jumps on Raised '26 View - TradingViewTradingView · Tue, 04 Aug 2026 17:42:00 GMTJazz Pharmaceuticals plc Stock 12‑Month Price Target Raised to $285, Implies 13% Upside - TradingViewTradingView · Tue, 04 Aug 2026 16:20:05 GMTJAZZ: Q2 revenue up 16% YoY to $1.21B; 2026 guidance raised on strong portfolio growth - TradingViewTradingView · Mon, 03 Aug 2026 23:31:26 GMTJazz Pharmaceuticals PLC reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 03 Aug 2026 21:39:18 GMTJazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales - TradingViewTradingView · Mon, 03 Aug 2026 20:55:52 GMTIreland's Jazz Pharma Q2 revenue beats estimates on Zepzelca higher sales - TradingViewTradingView · Mon, 03 Aug 2026 20:24:36 GMTJazz Pharmaceuticals plc Q2 2026: Revenue $1156.1M, EPS $2.78— 10-Q Summary - TradingViewTradingView · Mon, 03 Aug 2026 20:21:01 GMTJAZZ: Q2 2026 revenue rose 16% year-over-year, with net income of $192.8 million and strong product growth - TradingViewTradingView · Mon, 03 Aug 2026 20:14:05 GMT